Supernus Pharmaceuticals, Inc. (SUPN)

Supernus Pharmaceuticals Revenue

Supernus Pharmaceuticals had revenue of $175.69M in the quarter ending September 30, 2024, with 14.17% growth. This brings the company's revenue in the last twelve months to $651.97M, up 6.79% year-over-year. In the year 2023, Supernus Pharmaceuticals had annual revenue of $607.52M, down -8.95%.

• Revenue (ttm): $651.97M
• Revenue Growth: +6.79%
• P/S Ratio: 3.04
• Revenue / Employee: $999,957
• Employees: 652
• Market Cap: 1.99B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	607.52M	-59.72M	-8.95%
Dec 31, 2022	667.24M	87.46M	15.09%
Dec 31, 2021	579.78M	59.38M	11.41%
Dec 31, 2020	520.40M	127.64M	32.50%
Dec 31, 2019	392.76M	-16.14M	-3.95%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.